Internal Medicine, Hematology & Oncology · Westbrook, ME
NPI
1386614295
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
11 Rock Row Ste 120
Westbrook, ME, 04092
Phone (207) 303-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.5M
165,804 services
Medicare patients, 2024
354
Average age 74
Drug cost, 2024
$2.8M
1,174 prescriptions
Company payments, 2025
$52K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew C Dugan was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 19,500 times for 17 patients. In total Matthew C Dugan billed 165,804 services in 167 codes, and Medicare paid $3.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-17.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 19,500 | 17 | $2.32 | $45K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 17,250 | 16 | $0.88 | $15K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,000 | 16 | $44.67 | $625K |
| J0897 Injection, denosumab, 1 mg | Office | 5,340 | 18 | $20.65 | $110K |
| J9267 Injection, paclitaxel, 1 mg | Office | 2,674 | 12 | $0.08 | $215 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,031 | 64 | $0.09 | $178 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,410 | 13 | $35.72 | $50K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 970 | 42 | $0.25 | $247 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 912 | 11 | $3.53 | $3,217 |
| 85025 Blood Count | Office | 888 | 286 | $7.55 | $6,705 |
| 80053 Clinical Chemistry | Office | 847 | 262 | $10.27 | $8,697 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 790 | 20 | $0.69 | $547 |
| J9190 Injection, fluorouracil, 500 mg | Office | 699 | 13 | $2.30 | $1,609 |
| 36415 Venipuncture Blood Collection | Office | 625 | 246 | $8.61 | $5,380 |
| 96375 Injection Administration | Office | 486 | 87 | $11.77 | $5,720 |
By year: 2022 $3.3M for 172,623 services; 2023 $3.9M for 192,687 services; 2024 $3.5M for 165,804 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 888 | 286 | $7.55 | $6,705 |
| 80053 Clinical Chemistry | 847 | 262 | $10.27 | $8,697 |
| 36415 Venipuncture Blood Collection | 625 | 246 | $8.61 | $5,380 |
| 83550 Clinical Chemistry | 129 | 77 | $8.43 | $1,088 |
| 83540 Clinical Chemistry | 129 | 77 | $6.24 | $805 |
| 82728 Clinical Chemistry | 127 | 78 | $13.15 | $1,669 |
| 83735 Clinical Chemistry | 99 | 41 | $6.50 | $644 |
| 84443 Clinical Chemistry | 77 | 49 | $16.46 | $1,267 |
| 86301 Immunoassay | 72 | 23 | $20.39 | $1,468 |
| 82378 Clinical Chemistry | 44 | 32 | $17.87 | $786 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew C Dugan prescribed most often to Medicare patients was Lorazepam, with 55 prescriptions and refills. In total Matthew C Dugan wrote 1,174 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lorazepam Generic | 55 | 58 | 22 | $386 |
| Xarelto Rivaroxaban | 50 | 75 | 11 | $42K |
| Everolimus Generic | 45 | 45 | Under 11 | $111K |
| Levothyroxine Sodium Generic | 43 | 89 | 14 | $315 |
| Dexamethasone Generic | 41 | 45 | 18 | $472 |
| Bortezomib Generic | 34 | 34 | Under 11 | $28K |
| Omeprazole Generic | 34 | 63 | 12 | $472 |
| Ondansetron Odt Ondansetron | 33 | 33 | 17 | $898 |
| Eliquis Apixaban | 31 | 43 | Under 11 | $24K |
| Furosemide Generic | 30 | 34 | 13 | $76.75 |
| Gabapentin Generic | 30 | 46 | Under 11 | $371 |
| Famotidine Generic | 28 | 52 | Under 11 | $469 |
| Imatinib Mesylate Generic | 28 | 36 | Under 11 | $44K |
| Prednisone Generic | 25 | 38 | 14 | $87.75 |
| Prochlorperazine Maleate Generic | 25 | 27 | 14 | $470 |
Brand drugs: - claims; generic drugs: 872 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew C Dugan $52K ($52K in general payments such as food, travel and fees) from 28 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $28K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $28K |
| Exelixis Inc. EXEL | 16 | $13K |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $7,129 |
| Genentech USA, Inc. ROG.SW | 1 | $1,330 |
| Deciphera Pharmaceuticals Inc. | 4 | $706 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $503 |
| Abbvie Inc. ABBV | 6 | $163 |
| Janssen Biotech, Inc. JNJ | 4 | $101 |
| Daiichi Sankyo Inc. 4568.T | 4 | $94.29 |
| Adc Therapeutics America, Inc. | 3 | $52.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.